Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses

Intensive efforts have been made to identify features that could serve as biomarkers of aging. Yet, drug-based interventions aimed at lessening the detrimental effects of getting older are lacking. This is largely attributable to tissue-specificity, sex-related differences, and to the difficulty of identifying actionable targets, which continues to pose a significant challenge. Here, we implement a bioinformatics approach revealing that aging-associated increase of the transmembrane Ectodysplasin-A2-Receptor is a prominent tissue-independent alteration occurring in humans and other species, and is particularly pronounced in models of accelerated aging. We show that strengthening of the Ectodysplasin-A2-Receptor signalling axis in myogenic precursors and differentiated myotubes suffices to trigger potent parainflammatory responses, mirroring aspects of aging-driven sarcopenia. Intriguingly, obesity, insulin-resistance, and aging-related comorbidities, such as type-2-diabetes, result in heightened levels of the Ectodysplasin-A2 ligand. Our findings suggest that targeting the Ectodysplasin-A2 surface receptor represents a promising pharmacological strategy to mitigate the development of aging-associated phenotypes.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-02-23
DOI
https://doi.org/10.1038/s41467-025-56918-3
Citations
19
Primary Topic
dental development and anomalies
Type
article
Field-Weighted Citation Impact
15.31
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses

Laura Di Rito, Andrea David Re Cecconi, Rick Jansen, Luca Guarrera et al.
19 citations
Nature Communications
dental development and anomalies
15.31
article

Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses

Laura Di Rito, Andrea David Re Cecconi, Rick Jansen, Luca Guarrera, Giada Andrea Cassanmagnago, Sarah N. Mapelli, Ekaterina A. Semenova, Nikolay A. Kulemin, Martina Lunardi, Benedikt G. H. Schoser, Alexandra Kanygina, Marco Bolis, Brenda W.J.H. Penninx, Edward V. Generozov, Margherita Romeo, Rinat Sultanov, Ildus I. Ahmetov, Jenny van Dongen, Eco J. C. de Geus, Ilaria Craparotta, Arianna Vallerga, Rosanna Piccirillo, Maria Chiara Barbera, Francesca Checchi
article en
19 citations

Abstract

Intensive efforts have been made to identify features that could serve as biomarkers of aging. Yet, drug-based interventions aimed at lessening the detrimental effects of getting older are lacking. This is largely attributable to tissue-specificity, sex-related differences, and to the difficulty of identifying actionable targets, which continues to pose a significant challenge. Here, we implement a bioinformatics approach revealing that aging-associated increase of the transmembrane Ectodysplasin-A2-Receptor is a prominent tissue-independent alteration occurring in humans and other species, and is particularly pronounced in models of accelerated aging. We show that strengthening of the Ectodysplasin-A2-Receptor signalling axis in myogenic precursors and differentiated myotubes suffices to trigger potent parainflammatory responses, mirroring aspects of aging-driven sarcopenia. Intriguingly, obesity, insulin-resistance, and aging-related comorbidities, such as type-2-diabetes, result in heightened levels of the Ectodysplasin-A2 ligand. Our findings suggest that targeting the Ectodysplasin-A2 surface receptor represents a promising pharmacological strategy to mitigate the development of aging-associated phenotypes.

Nature CommunicationsVol. 16(1)
Plekhanov Russian University of Economics (RU), SIB Swiss Institute of Bioinformatics (CH), Kazan State Medical University (RU), University of Milan (IT), Mario Negri Institute for Pharmacological Research (IT), LMU Klinikum (DE), Institute of Oncology Research (CH), Amsterdam Neuroscience (NL), GGD Amsterdam (NL), Amsterdam University Medical Centers (NL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Humanitas Research Hospital (IT), Volga Region State Academy of Physical Culture, Sports and Tourism (RU), Università della Svizzera italiana (CH), Liverpool John Moores University (GB), Federal Medical-Biological Agency (RU), University of Milano-Bicocca (IT), Ludwig-Maximilians-Universität München (DE), Vrije Universiteit Amsterdam (NL)
Good health and well-being
Openalex Percentile: Top 1%
dental development and anomalies
15.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.